Sponsored Webinar: Understanding the RILIEF Trial

The IgG4ward! Foundation is pleased to present this sponsored educational webinar made possible through the support of Sanofi.

Join internationally recognized IgG4-RD experts for a 45-minute educational webinar exploring the RILIEF Phase 3 clinical trial evaluating rilzabrutinib for IgG4-related disease (IgG4-RD).

Designed for patients, caregivers, family members, healthcare professionals, and anyone interested in learning more about IgG4-RD clinical research, this webinar will provide an accessible overview of the science behind the study, the design of the clinical trial, and the important processes used to ensure the integrity of clinical research.

What you'll learn

During this webinar, our expert faculty will discuss:

• Why B cells play a central role in IgG4-related disease

• The scientific rationale behind the RILIEF Phase 3 clinical trial

• The design and objectives of the study

• The role of the independent adjudication committee in confirming trial eligibility and evaluating disease flares

• How clinical trials help advance research and improve future treatment options

• Answers to audience questions during a live Q&A session

Whether you are interested in learning more about clinical research, considering participation in future studies, or simply looking to better understand how potential new therapies are evaluated, this webinar offers a unique opportunity to hear directly from physicians actively advancing the field of IgG4-RD.

Featured Faculty

Dr. Mollie Carruthers – Host

Dr. Corey Perugino

Dr. Matthew Baker

Date: Friday, July 31, 2026
Time: 12:00–12:45 PM ET

Registration is free, but advance registration is required.

CLICK HERE TO REGISTER

Disclaimer: The information presented during this webinar is intended for educational purposes only and should not be considered medical advice. Participants should consult their healthcare provider regarding questions about their individual care.